Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease

[1]  G. Wahl,et al.  Stem cells, cancer, and cancer stem cells , 2012 .

[2]  J.,et al.  The New England Journal of Medicine , 2012 .

[3]  B. Homey,et al.  Chemokines in tumor-associated angiogenesis , 2009, Biological chemistry.

[4]  S. Mirza,et al.  Prognostic Relevance of Promoter Hypermethylation of Multiple Genes in Breast Cancer Patients , 2009, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[5]  H. Bojar,et al.  Gene expression of circulating tumour cells in breast cancer patients , 2009, European journal of medical research.

[6]  E. van Marck,et al.  The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients , 2009, British Journal of Cancer.

[7]  Robin L. Jones,et al.  Methylated NEUROD1 Promoter is a Marker for Chemosensitivity in Breast Cancer , 2008, Clinical Cancer Research.

[8]  Masaru Shinozaki,et al.  Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors , 2008, Breast Cancer Research.

[9]  M. Schmelzle,et al.  Modern therapy of rectal carcinoma. , 2008, European journal of medical research.

[10]  C. Poremba,et al.  Interdisciplinary treatment of primary hepatic angiosarcoma: emergency tumor embolization followed by elective surgery. , 2007, European journal of medical research.

[11]  P. Guldberg,et al.  A ligation assay for multiplex analysis of CpG methylation using bisulfite-treated DNA , 2007, Nucleic acids research.

[12]  Xin Hu,et al.  Correlation between CpG methylation profiles and hormone receptor status in breast cancers , 2007, Breast Cancer Research.

[13]  P. Paterlini-Bréchot,et al.  Circulating tumor cells (CTC) detection: clinical impact and future directions. , 2007, Cancer letters.

[14]  H. Matthaei,et al.  Current status of radical systematic lymphadenectomy in pancreatic cancer--a review of the literature. , 2007, European journal of medical research.

[15]  K. Dardoufas,et al.  Cell‐free DNA and RNA in Plasma as a New Molecular Marker for Prostate and Breast Cancer , 2006, Annals of the New York Academy of Sciences.

[16]  E. van Marck,et al.  Prognostic significance of disseminated tumor cells as detected by quantitative real-time reverse-transcriptase polymerase chain reaction in patients with breast cancer. , 2006, Clinical breast cancer.

[17]  T. Fehm,et al.  A pooled analysis of bone marrow micrometastasis in breast cancer. , 2005, The New England journal of medicine.

[18]  N. Lane,et al.  Methods for isolating circulating epithelial cells and criteria for their classification as carcinoma cells. , 2005, Cytotherapy.

[19]  T. Ratliff.  Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer. , 2005, The Journal of urology.

[20]  A. Giuliano,et al.  Distinct Hypermethylation Profile of Primary Breast Cancer Is Associated with Sentinel Lymph Node Metastasis , 2005, Clinical Cancer Research.

[21]  Alison Stopeck,et al.  Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  Martin Widschwendter,et al.  Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients. , 2005, Cancer research.

[23]  Alison Stopeck,et al.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.

[24]  J. Califano,et al.  Quantitative Detection of Promoter Hypermethylation of Multiple Genes in the Tumor, Urine, and Serum DNA of Patients with Renal Cancer , 2004, Cancer Research.

[25]  K. Pantel,et al.  Detection and Characterization of Circulating Microsatellite‐DNA in Blood of Patients with Breast Cancer , 2004, Annals of the New York Academy of Sciences.

[26]  Peter A. Jones,et al.  Epigenetics in human disease and prospects for epigenetic therapy , 2004, Nature.

[27]  A. Cheung,et al.  Detection of hypermethylated genes in tumor and plasma of cervical cancer patients. , 2004, Gynecologic oncology.

[28]  C. Moon,et al.  Detection of Promoter Hypermethylation of Multiple Genes in the Tumor and Bronchoalveolar Lavage of Patients with Lung Cancer , 2004, Clinical Cancer Research.

[29]  A. Harris,et al.  Quantitation of circulating DNA in the serum of breast cancer patients by real-time PCR , 2004, British Journal of Cancer.

[30]  M. Widschwendter,et al.  DNA methylation in serum of breast cancer patients: an independent prognostic marker. , 2003, Cancer research.

[31]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[32]  A. Grothey,et al.  Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer. , 2003, Cancer research.

[33]  Martin Widschwendter,et al.  DNA methylation and breast carcinogenesis , 2002, Oncogene.

[34]  D. Sidransky,et al.  Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. , 2002, Cancer research.

[35]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[36]  P. Laird,et al.  DNA Methylation: An Alternative Pathway to Cancer , 2001, Annals of surgery.

[37]  K. Miller,et al.  Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids. , 2000, Cancer research.

[38]  P. Steeg,et al.  Molecular biology of breast cancer metastasis: Genetic regulation of human breast carcinoma metastasis , 2000, Breast Cancer Research.

[39]  J. Goeminne,et al.  Pitfalls in the detection of disseminated non-hematological tumor cells. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[40]  V. Vasioukhin,et al.  The Origin and Mechanism of Circulating DNA , 2000, Annals of the New York Academy of Sciences.

[41]  J. Herman,et al.  Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. , 2000, Cancer research.

[42]  H. Leonhardt,et al.  DNA methylation, nuclear structure, gene expression and cancer , 2000, Journal of cellular biochemistry. Supplement.

[43]  D. Slamon,et al.  Identification of differentially expressed genes associated with HER-2/neu overexpression in human breast cancer cells. , 1999, Nucleic acids research.

[44]  R. Cote,et al.  Detection and clinical importance of micrometastatic disease. , 1999, Journal of the National Cancer Institute.

[45]  Jose M. Silva,et al.  Presence of tumor DNA in plasma of breast cancer patients: clinicopathological correlations. , 1999, Cancer research.

[46]  M. Provencio,et al.  Aberrant DNA methylation of the p16INK4a gene in plasma DNA of breast cancer patients , 1999, British Journal of Cancer.

[47]  R. Cardiff,et al.  Elevated expression of activated forms of Neu/ErbB‐2 and ErbB‐3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer , 1999, The EMBO journal.

[48]  W. Lau,et al.  Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. , 1999, Cancer research.

[49]  J. Herman,et al.  Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. , 1999, Cancer research.

[50]  S. Rodenhuis,et al.  The detection of minimal numbers of contaminating epithelial tumor cells in blood or bone marrow: use, limitations and future of RNA-based methods. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[51]  A. Purushotham,et al.  Putative markers for the detection of breast carcinoma cells in blood. , 1998, British Journal of Cancer.

[52]  C. Morrow,et al.  Methylation-mediated regulation of the glutathione S-transferase P1 gene in human breast cancer cells. , 1998, Gene.

[53]  R. Osamura,et al.  A study of 46 cumulative breast cancer autopsy cases. , 1997, The Tokai journal of experimental and clinical medicine.

[54]  W. Muller,et al.  Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors. , 1994, Molecular and cellular biology.

[55]  M. Caligiuri,et al.  A cell initiating human acute myeloid leukaemia after transplantation into SCID mice , 1994, Nature.

[56]  N. Peat,et al.  Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. , 1990, The Journal of biological chemistry.

[57]  Yeu‐Tsu N. Lee,et al.  Breast carcinoma: Pattern of metastasis at autopsy , 1983, Journal of surgical oncology.

[58]  S. Cho,et al.  Causes of death and metastatic patterns in patients with mammary cancer. Ten-year autopsy study. , 1980, American journal of clinical pathology.

[59]  B. Shapiro,et al.  Free DNA in the serum of cancer patients and the effect of therapy. , 1977, Cancer research.